Amethyst Radiotherapy Romania

What Amethyst Radiotherapy Romania does

Amethyst Radiotherapy Romania is a private network of six radiotherapy and oncology clinics operating across major Romanian population centers (Bucharest/Otopeni, Cluj-Napoca, Timișoara, Alba Iulia, Piatra Neamț, and Satu Mare), with the primary operating entity Radiotherapy Center Cluj S.R.L. headquartered in Florești, Cluj. The network is part of a broader European Amethyst Group that operates 15–18 clinics continent-wide, with the Amethyst Radiotherapy Centre in Metz, France functioning as the clinical training and reference hub.

The company delivers comprehensive cancer care spanning radiotherapy (IMRT-VMAT, IGRT, stereotactic, 3D-CRT, brachytherapy, curative and palliative), medical oncology (chemotherapy and immunotherapy), diagnostic imaging (CT and MRI for treatment planning), and supportive services (psychological counselling, nutritional support, and pain management). The core technology platform is built on Elekta linear accelerators, which the company describes as uniquely deployed in Romania and capable of delivering treatment sessions in 8–12 minutes with 3–5 minutes of active irradiation. Every patient case is reviewed by a formal multidisciplinary tumor board, with real-time cross-consultation to the French Metz centre. The network employs 250 multidisciplinary professionals and has cumulatively treated approximately 18,000 patients across 725,000+ treatments.

The business model is a contracted-provider, fee-for-service arrangement under Romania's universal healthcare framework: all oncology treatments are fully reimbursed by CNAS (Casa Națională de Asigurări de Sănătate) for insured patients, removing out-of-pocket cost as a barrier. Patient acquisition runs through a national call centre (021 9368) and online appointment booking, with referrals from oncologists, GPs, and hospital departments. Revenue is therefore tied directly to CNAS contracted tariffs and patient volume across the six sites. The company is privately held under Romanian S.R.L. law, with no disclosed funding rounds, no venture or private-equity investment identified in the source material.

Name

Amethyst Radiotherapy Romania

Legal name

Radiotherapy Center Cluj S.R.L.

Website

https://amethyst-radiotherapy.ro

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

51–100 employees

Short description

Amethyst Radiotherapy Romania operates six private oncology and radiotherapy clinics across Romania, delivering IMRT-VMAT, IGRT, stereotactic radiotherapy, chemotherapy, and immunotherapy fully reimbursed by CNAS, serving insured Romanian cancer patients with a 250-person multidisciplinary team.

Ownership category

akta.pro rank

Product category

Oncology and Radiotherapy Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Radiotherapy services
• Oncology treatments
• Cancer care
• Medical imaging
• Chemotherapy services

Headquarters

HQ city

Otopeni (Bucharest)

HQ country

Romania

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. CNAS Reimbursed Oncology Services: All oncology treatments — radiotherapy, chemotherapy, immunotherapy — are fully covered by Romania's Casa Națională de Asigurări de Sănătate (CNAS). Patients incur no out-of-pocket costs for treatments included in the National Oncology Program, provided they hold a valid Romanian health insurance card and complete medical file. The company operates as a contracted provider under Romania's universal healthcare coverage framework, with revenue flowing from the national health insurance system based on contracted tariffs and patient volume.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels10 records

Core offering

Amethyst Radiotherapy Romania operates a network of six specialized oncology clinics across Romania (Bucharest/Otopeni, Cluj-Napoca, Timișoara, Alba Iulia, Piatra Neamț, and Satu Mare), delivering radiotherapy, medical oncology (chemotherapy and immunotherapy), diagnostic imaging (CT and MRI), and supportive care for cancer patients. The clinics are part of the pan-European Amethyst Group, use Elekta linear accelerators, and provide multidisciplinary tumor-board-driven treatment plans reimbursed through the Romanian National Health Insurance (CNAS).

Product overview

Amethyst Radiotherapy Romania operates as a network of oncology centers offering comprehensive cancer treatment services. The core offering includes radiotherapy services (curative, stereotactic, palliative, brachytherapy, and IMRT-VMAT treatments), medical imaging (CT and MRI), medical oncology (chemotherapy and immunotherapy), and supportive therapies (psychological counseling, nutrition, and pain control). All treatments are fully covered through CNAS (Casa Națională de Asigurări de Sănătate) national health insurance. The network operates 6 centers across Romania (Bucharesti, Cluj-Napoca, Timisoara, Alba Iulia, Piatra Neamt, Satu-Mare) with approximately 18,000 patients treated and 725,689 treatments performed.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapy Services
• IMRT-VMAT

Quantifiable outcome

• 18,000 patients treated across Amethyst Romania centres
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• CNAS (Casa Națională de Asigurări de Sănătate)coreStrategic or Co-development PartnerThe National Health Insurance House of Romania (CNAS) is the primary public payer for oncology services. Amethyst is a contracted CNAS provider, enabling all oncology treatments — radiotherapy, chemotherapy, and immunotherapy — to be fully reimbursed for insured patients under the National Oncology Program. This partnership is fundamental to Amethyst's business model, as it eliminates out-of-pocket costs for patients and provides the revenue stream for the company.
• Amethyst Radiotherapy Centre Metz (France)coreStrategic or Co-development PartnerThe Amethyst Radiotherapy Centre in Metz, France, serves as the clinical training hub and reference centre for Amethyst Romania. The Romanian medical team underwent training at the Metz centre to acquire skills in IMRT-VMAT techniques. The two teams — Romania and France — consult in real time on medical cases via state-of-the-art information technology. The French centre provides clinical oversight, protocol standardization, and second-opinion consultation for complex cases.
• Elekta (Medical Technology Provider)coreTechnology or IntegrationElekta is the manufacturer of the linear accelerators installed at Amethyst Romania centres. The Elekta VMAT system is described as the most advanced radiotherapy technology globally and is uniquely featured in Romania through Amethyst. Elekta provides the hardware platform enabling IMRT, VMAT, and IGRT capabilities, which form the core clinical differentiation of Amethyst's radiotherapy services.
• Cancer.net (AJCP / ASCO)minorOthersCancer.net (a patient information resource from the American Society of Clinical Oncology) is cited as a source for oncology information content published on the Amethyst website. This represents a content/educational partnership where Amethyst references and links to ASCO's patient education materials.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Sanador: Large Romanian private hospital chain with oncology, imaging and ambulatory services under CNAS contracts. Comparable as a multi-specialty Romanian private incumbent with overlapping radiotherapy and medical oncology capabilities.
• Regina Maria (Rețeaua de Sănătate Regina Maria): One of Romania's largest private healthcare networks with outpatient clinics, imaging and oncology services. Comparable as a CNAS-contracted multi-specialty incumbent competing for the same insured oncology patients, though Regina Maria does not focus exclusively on radiotherapy.
• MedLife: Romania's largest private healthcare network, offering ambulatory and inpatient services including oncology. While broader in scope, MedLife's oncology offerings and CNAS-contracted ambulatory services intersect with Amethyst's radiotherapy specialty, making it a multi-specialty incumbent competing for the same insured patient pool.
• Medicover Romania: International private healthcare provider (Sweden-headquartered) with a sizeable Romanian network of clinics, hospitals and diagnostics. Comparable on CNAS-contracted ambulatory services and outpatient oncology offering, competing for insured Romanian patients in the same delivery model.
• GenesisCare (European operations): One of the world's largest integrated oncology networks, with European radiotherapy centres using Elekta and Varian linacs. Comparable as a multi-country radiotherapy pure-play with advanced VMAT/IMRT technology and multidisciplinary care models similar to Amethyst's European network.

Direct peers

• Hiperdia Romania: Romanian private oncology and diagnostic imaging centre chain, historically known for advanced radiotherapy. A direct competitor in CNAS-reimbursed outpatient oncology and modern linac-based radiotherapy services in the Romanian market.
• Affidea Romania: Affidea operates private diagnostic imaging and oncology centres across Romania and Europe, including advanced radiotherapy services. It directly competes with Amethyst in CNAS-reimbursed outpatient oncology, matching Amethyst's model of insurer-contracted specialty care with modern linac technology.
• Spitalul OncoFort (OncoFort): Romanian private oncology hospital in Bucharest providing chemotherapy, radiotherapy and oncology surgery under CNAS reimbursement. A direct peer on the core radiotherapy + chemo + tumour-board offering within the same CNAS framework.

Others

• Elekta AB (technology partner, peer comparison): Swedish manufacturer of the linear accelerators and software (VMAT, IMRT, IGRT) installed across Amethyst Romania's six centres. Relevant ecosystem comparison given Amethyst's stated uniqueness in Romania derives directly from Elekta's technology stack.

Regional players

• Institutul Oncologic „Prof. Dr. Alexandru Trestioreanu" București (IOB): Romania's flagship public oncology hospital offering radiotherapy, chemo and surgery. Comparable on core oncology service lines and CNAS funding, but operates as a state institution with different cost structure and patient selection dynamics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@AmethystRadiotherapy
• Facebookfacebook.com/AmethystRadiotherapy
• LinkedInlinkedin.com/company/amethyst-radiotherapy-center-romania
• Instagraminstagram.com/amethyst.romania

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amethyst Radiotherapy Romania